Professional
Added to YB: 2024-09-06
Pitch date: 2024-06-30
ENOV [bullish]
Enovis Corporation
-41.49%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally.
Market Cap
$1.7B
Pitch Price
$45.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.89
P/E
-1.24
EV/Sales
1.40
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Diamond Hill Select Fund Portfolio Holding: Enovis Corporation
ENOV: Innovative medtech co. pressured by acquisition integration. Market undervalues ability to drive above-market organic growth via cross-selling, accretive M&A & margin expansion. Well-positioned to continue taking share despite COVID surgery backlog winddown.
Read full article (1 min)